7-Substituted Purine Derivatives for Immunosuppression
US2009023723A1
Purinone derivatives for treating neurodegenerative diseases
US2007225304A1
Aminopurine derivatives for treating neurodegenerative diseases
US2009005568A1
Substituted 2-aminothiazoles for treating neurodegenerative diseases
US2008312215A1
Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders
WO2006055918A2
One-dimensional qsar models
CN101076524A
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
MXPA06002372A
2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders.
US2004209878A1
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
WO2004063192A1
Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
WO2004069829A1
(2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis
US2004147559A1
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
US6900213B2
Bisaryl derivatives having FSH modulatory activity
US7037916B2
Pyrimidine derivatives as IL-8 receptor antagonists
US2003149041A1
Pyrimidine and triazine kinase inhibitors
US7038054B1
Diazabicyclononane scaffold for combinatorial synthesis
